Work

The end of balloons? Our take on the UK-REBOA trial

Year: 2023

Type: editorial

Abstract: BACKGROUND: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is increasingly used. The recently published UK-REBOA trial aimed to investigate patients suffering haemorrhagic shock and randomized to standard care alone or REBOA as adjunct to standard care and concludes that REBOA may increase the mortality. MAIN BODY: In this commentary we try to balance the discussion on use of REBOA and address limitations in the UK-REBOA trial that may have influenced the outcome of the study. CONCLUSION: The situation is complex, and the patients are in extremis. In summary, we do not think this is the end of balloons.

Source: Scandinavian Journal of Trauma Resuscitation and Emergency Medicine

DOI: 10.1186/s13049-023-01142-5

Authors: Jostein Rødseth Brede, Marius Rehn

Institutions: Stiftelsen Norsk Luftambulanse, St Olav's University Hospital, Oslo University Hospital, University of Oslo

Language: English

Topic: Trauma, Hemostasis, Coagulopathy, Resuscitation

Subfield: Critical Care and Intensive Care Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,890

OpenAlex ID: W4388041014

Cites: 23

Cited by: 11

Related to: 10